Large-scale testing (Phase 3)Study completedNCT00105547What this trial is testingEfficacy Study of MPC-7869 to Treat Patients With Alzheimer'sWho this might be right forAlzheimer DiseaseDementia Myrexis Inc. 1,600
Not applicableLooking for participantsNCT06539169What this trial is testingFLOWER: Following Longitudinal Outcomes With Epidemiology for Rare DiseasesWho this might be right forAlpha-ThalassemiaBeta-ThalassemiaAmyloidosis+14 more xCures 1,000
Large-scale testing (Phase 3)Study completedNCT01404169What this trial is testingA 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's DiseaseWho this might be right forAlzheimer's Type Dementia Eisai Limited 260
Testing effectiveness (Phase 2)Study completedNCT01466088What this trial is testingEfficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)Who this might be right forAlzheimer's Disease Targacept Inc. 386
Large-scale testing (Phase 3)Ended earlyNCT06736509What this trial is testingAn Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension StudyWho this might be right forAgitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation, Psychomotor Axsome Therapeutics, Inc. 139
Large-scale testing (Phase 3)Study completedNCT02442765What this trial is testingEfficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeWho this might be right forAgitation in Patients With Dementia of the Alzheimer's Type Otsuka Pharmaceutical Development & Commercialization, Inc. 387
Not applicableStudy completedNCT03732053What this trial is testingThe Effectiveness of Global Postural Reeducation on Alzheimer Disease PatientsWho this might be right forAlzheimer's Type DementiaCognitive DeclinePostural; Strain Universidad Católica San Antonio de Murcia 135
Post-approval studies (Phase 4)Study completedNCT03185208What this trial is testingLithium As a Treatment to Prevent Impairment of Cognition in EldersWho this might be right forMild Cognitive Impairment Ariel Gildengers, MD 83
Testing effectiveness (Phase 2)Study completedNCT00104273What this trial is testingRasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)Who this might be right forDementiaAlzheimer's Disease Teva Branded Pharmaceutical Products R&D, Inc. 376
Testing effectiveness (Phase 2)Study completedNCT02632786What this trial is testingThe PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) AmyloidosisWho this might be right forAL Amyloidosis Prothena Biosciences Ltd. 129
Not applicableNot Yet RecruitingNCT06416267What this trial is testingRisk and Clinical Consequences of Low Count Monoclonal B-cell Lymphocytosis (LC MBL)Who this might be right forMonoclonal B-Cell LymphocytosisChronic Lymphocytic LeukemiaInfections+6 more University of Haifa 1,500
Testing effectiveness (Phase 2)Looking for participantsNCT06745583What this trial is testingAssess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease PatientsWho this might be right forMild, Moderate, or Severe Alzheimer's Disease Elixiron Immunotherapeutics Inc. 15
Large-scale testing (Phase 3)Study completedNCT00814801What this trial is testingAn Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Janssen Pharmaceutical K.K. 580
Early research (Phase 1)Study completedNCT03030105What this trial is testingStudy to Evaluate the Effects of BPN14770 on Scopolamine-induced Cognitive Impairment in Healthy VolunteersWho this might be right forAlzheimer Disease Tetra Discovery Partners 38
Large-scale testing (Phase 3)Study completedNCT00041678What this trial is testingStudy of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's TypeWho this might be right forAlzheimer Disease Otsuka Pharmaceutical Development & Commercialization, Inc.
Not applicableNot Yet RecruitingNCT05796037What this trial is testingAn Observational Study of Patients Living With Chronic Neurological DiseasesWho this might be right forNeurological Diseases or ConditionsDementia of Alzheimer TypeAlzheimer Disease+3 more Target PharmaSolutions, Inc. 1,500,000
Large-scale testing (Phase 3)Study completedNCT03393520What this trial is testingAssessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeWho this might be right forAgitation in Patients With Dementia of the Alzheimer's Type Otsuka Pharmaceutical Development & Commercialization, Inc. 601
Not applicableStudy completedNCT02460783What this trial is testingIntermittent Calorie Restriction, Insulin Resistance, and Biomarkers of Brain FunctionWho this might be right forAlzheimer's DiseaseObesityDiabetes Mellitus National Institute on Aging (NIA) 129
Testing effectiveness (Phase 2)Study completedNCT00153010What this trial is testingAn Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's TypeWho this might be right forAlzheimer Disease Boehringer Ingelheim 430
Large-scale testing (Phase 3)Active Not RecruitingNCT06125951What this trial is testingEffect of 10 mg Xanamem on Dementia Due to Alzheimer's DiseaseWho this might be right forDementia ModerateDementia, MildAlzheimer Disease Actinogen Medical 247